Serrapeptase
Proteolytic enzyme used to reduce post-operative swelling and ease chronic sinusitis symptoms, with limited but promising anti-inflammatory evidence.
Serrapeptase
Proteolytic enzyme used to reduce post-operative swelling and ease chronic sinusitis symptoms, with limited but promising anti-inflammatory evidence.
Niche anti-inflammatory enzyme worth considering for sinus or post-surgical swelling, but evidence is limited and mixed.
Serrapeptase is a proteolytic enzyme originally isolated from the bacterium Serratia marcescens. It has been used in Japan and Europe for decades to manage inflammation, edema, and mucus buildup. The enzyme is thought to break down fibrin and other proteins involved in inflammatory exudates, potentially improving fluid drainage and reducing swelling. Clinical studies suggest it may help reduce post-operative swelling, alleviate symptoms of chronic sinusitis, and ease pain from dental inflammation. Some limited research also explored its use for fibrocystic breast disease. It is generally consi
Proven Benefits
Protocol
Onset Time
Who Should Consider
How It Works
Serrapeptase is absorbed from the intestine into the bloodstream, where it acts as a protease to degrade non-living proteins such as fibrin, mucus, and inflammatory byproducts. By breaking down fibrin and damaged tissue at sites of inflammation, it may reduce edema and improve microcirculation, while its mucolytic activity can thin viscous secretions in the respiratory tract.